The GEO Group, Inc. Message Board
-
ok dude. ok.
seems like you are wrong homie -
JBS wanted Marfrig's Seara poultry unit, not anymore PPC
- Reply to
Pilgrim's Parent Company JBS Buys Brazil's Seara Poultry Unit
by web_specialist2000 •Jun 8, 2013 10:01 PMThis news is not good for PPC longs as JBS just put on the table they are not interested in PPC.
Expect Monday carnage of sharesSentiment: Strong Sell
-
PPC was severely overbought today...up 21% on no news. Fund had to buy his position by end of today at all costs. DUMPING will start Monday.
Hope u longs sold today.Sentiment: Strong Sell
-
don't believe everything analysts say.
$1000 target for internet bubble stocks remember? -
SAC Capital finished selling off their AMRN position yesterday for Fund redemption preparation
- Reply to
Once again AF and shorts trying to tell only part of the story bc they have no clue..
by harveyspecter357 •Jun 6, 2013 11:46 AMisn't there an advisory committee on EVERY drug sNDA indication?
-
nice man up twocorn
-
AMRN's IR person left the company last month. Not sure if any replacement has hired
-
anyone care to compare the health benefits and detriments of the 2?
-
and #$%$ r u doing right now
-
typical amrn price action on patent news. sad but the trend
-
what was last weeks' symphony number?
-
u r definitely full of it. prescription of Vascepa actually COSTS LESS than Plusepa.
-
once we see major tv network Vascepa ads, expect script numbers to EXPLODE!
-
nice short this thing is.
- Reply to
Sorry to say this, but this board has become quite lost
by lev.lutskii •May 14, 2013 7:45 AMthen what the heck r u doing here. go back to ST and IH.
this got to be one of the most stupidest posts of the day (aside from bullrunners) -
cuz he don't know jack #$%$. compare any other new drug launch by a small biotech and u will see that Vascepa is launching just fine
- Reply to
Oh....so now Motley Fool comes out with a positive piece on Amarin 2:21 EST
by nukemtiltheyglow •May 10, 2013 4:53 PMthey name themselves Fool for a reason